Pregled bibliografske jedinice broj: 1007662
Mumps neurovirulence testing – an obstacle in development of a safe mumps vaccine
Mumps neurovirulence testing – an obstacle in development of a safe mumps vaccine // Viral neurovirulence research and new alternatives for in vivo testing
Zagreb, Hrvatska, 2019. (pozvano predavanje, nije recenziran, neobjavljeni rad, znanstveni)
CROSBI ID: 1007662 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Mumps neurovirulence testing – an obstacle in development of a safe mumps vaccine
Autori
Ivančić-Jelečki, Jelena ; Mažuran, Renata ; Šantak, Maja ; Forčić, Dubravko ; Lang Balija, Maja ; Košutić Gulija, Tanja ; Jagušić, Maja ; Jug, Renata
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, neobjavljeni rad, znanstveni
Skup
Viral neurovirulence research and new alternatives for in vivo testing
Mjesto i datum
Zagreb, Hrvatska, 21.02.2019
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Nije recenziran
Ključne riječi
mumps ; virus neurovirulence ; test on animals ; alternative methods ; 3R principle
Sažetak
Mumps is an acute communicable respiratory infection, caused by mumps virus (family Paramyxoviridae). While its most prominent symptom, parotitis, is relatively benign, more serious reactions such as meningitis or encephalitis occur in approx. 1- 10% of cases. These complications arise because of the highly neurotropic nature of the virus: in approx. 65% of cases infection of the central nervous system occurs. All currently available mumps vaccines are based on live attenuated strains and are usually given as part of tricomponent MMR vaccine (measles-mumps-rubella). Some mumps vaccine strains are insufficiently attenuated and although neurological side effects occur only in very small percentage of vaccinees, they add to public reluctance to vaccination and have even lead to cessation of mumps vaccination in some countries (e.g. Japan). Because of the neurovirulent properties of wild-type mumps viruses, testing of live mumps vaccines for neurovirulence is required by national regulatory organizations. Currently, there are two main methods for mumps neurovirulence testing: 1) inoculation of monkeys and measurement of following inflammatory reactions and description of histopathological changes ; 2) intracerebral inoculation of newbourn rats and measurement of hydrocephalus that develops during inspection period of 30-days. Neither of two methods gives accurate prediction of strains' neurovirulence potential in humans. Monkey-based test is extremely expensive and often inaccurate ; rat-based test seems to have greater predictive value but it is very imprecise.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Javno zdravstvo i zdravstvena zaštita, Biotehnologija
POVEZANOST RADA
Projekti:
KK.01.1.1.01.0006
Ustanove:
Imunološki zavod d.d.,
Sveučilište u Zagrebu
Profili:
Maja Šantak
(autor)
Jelena Ivančić-Jelečki
(autor)
Maja Jagušić
(autor)
Dubravko Forčić
(autor)
Renata Mažuran
(autor)
Maja Lang Balija
(autor)
Tanja Košutić Gulija
(autor)